Wide range of drug company executives from the C-suite to sales reps and manufacturing managers. Readership also includes contractors and others with a professional interest in the pharma industry. U.S. represents the largest audience segment followed by U.K. and Indian markets. Readership in other European and Asian markets is growing rapidly, particularly in countries with big concentrations of pharma companies, such as Germany, Denmark, France, China and Japan.
Broad coverage serving a wide range of specific functional interests including: manufacturing regulation, financial management, quality control and production methods; shareholder pressure and speed-to-market strategies; sales and marketing access to physicians and navigating payer rules; the impact of pricing and partnerships on the pipeline and the influence of big data, executive moves and social media on it all.